SARS-CoV-2: Review of Conditions Associated With Severe Disease and Mortality

Joshua Eyitemi1, Britanie Thomas1, Yazmin Ramos1

  • 1School of Public Health, University of Saskatchewan, Saskatoon, SK, Canada.

Insights

Certain chronic diseases like cancer, diabetes, and COPD significantly increase the risk of severe outcomes from COVID-19. Identifying these comorbidities helps prioritize at-risk populations for better resource allocation and reduced mortality.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The 2019 Coronavirus Disease (COVID-19) emerged as a significant global health crisis.
  • Understanding risk factors is crucial for managing patient outcomes and public health strategies.

Purpose of the Study:

  • To identify pre-existing comorbidities in COVID-19 patients that are associated with increased risk of complications, severe illness, and death.
  • To highlight specific chronic diseases that may predispose individuals to adverse COVID-19 outcomes.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases including PubMed, Google Scholar, and Medline.
  • Thirty-seven articles detailing 15 different chronic diseases were selected for review.

Main Results:

  • Cancer, diabetes, lymphopenia, hypertension, kidney disease, smoking, chronic obstructive pulmonary disease (COPD), and organ transplant were identified as significant risk factors.
  • Coronary artery disease, cerebrovascular disease, HIV/AIDS, asthma, and liver disease require further investigation for their impact on COVID-19 severity.

Conclusions:

  • The study establishes a clear association between several chronic diseases and increased COVID-19 severity.
  • Identifying at-risk populations with these comorbidities is essential for targeted interventions and resource allocation to reduce mortality.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
366
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
457
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
319
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
429
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
287
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
273